No Picture
News

Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024

WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that its industry-leading team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting. Charles River will present technology-driven capabilities […]

No Picture
News

2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron

CAMBRIDGE, Mass.–(BUSINESS WIRE)– #TSVT–2seventy bio, Inc. (Nasdaq: TSVT), announced today the completion of the asset purchase agreement (“APA”) by Regeneron Pharmaceuticals, Inc. Under the terms of the APA, Regeneron has acquired all oncology and autoimmune […]

Boston Cambridge Biotech Trending News

STAT+: Critics say U.K. decision on ALS drug could have ‘chilling effect’ on access to new genetic medicines

LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and […]